Evaluation of the cardiopulmonary effects of repurposed COVID-19 therapeutics in healthy rats

Abstract Hydroxychloroquine (HCLQ), favipiravir (FAVI), molnupiravir (MOL) and dexamethasone (DEX) are recently used drugs, some of which are currently used in the treatment of Coronavirus Disease (COVID-19). We aimed to investigate the cardiovascular and pulmonary effects of MOL, HCLQ, FAVI and DEX...

Полное описание

Библиографические подробности

Главные авторы:	Onural Ozhan, Azibe Yildiz, Busra Bakar, Ahmet Ulu, Zeynep Kucukakcali, Elif Karaca, Nigar Vardi, Burhan Ates, Hakan Parlakpinar
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Nature Portfolio 2026-01-01
Серии:	Scientific Reports
Предметы:	COVID-19 Hydroxychloroquine Favipiravir Molnupiravir Dexamethasone
Online-ссылка:	https://doi.org/10.1038/s41598-025-31048-4
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!